Sick people being condemned to a painful, lingering death due to using a medicinal plant that doesn’t have the blessing of Big Pharma? It’s the American Way!
After being diagnosed with liver cancer in 2009, Norman B. Smith applied to the liver transplant list at Cedar-Sinai hospital. While waiting for a transplant, Mr. Smith underwent chemotherapy in an attempt to destroy the cancer eating away at his liver. This caused severe side-effects, common to many cancer patients. In an attempt to curb the pain, and on the recommendation of his oncologist, Mr. Smith began using medical marijuana. Cannabis has become increasingly common as a medicine of choice for patients undergoing chemotherapy, since it increases appetite and reduces pain—minimizing the chance of a patient developing cancer related wasting syndrome. Finally, in September of 2010, Mr. Smith was notified that he was eligible for a liver transplant and was placed on the liver transplant list. Mr. Smith continued his treatment and submitted to drug testing per the hospital’s transplant list policy. After testing positive for THC (one of the active chemicals in marijuana), Mr. Smith was taken off the transplant list and denied a life saving procedure.